Cancer Pain Market Report

Global and Region Cancer Pain Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：181
  • REPORT CODE：GMM938195
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.

    The report details the trend, potential and market size of Cancer Pain market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Painmarket, defines the market attractiveness level of Cancer Pain market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer Pain industry, describes the types of Cancer Pain market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Pain market and the development prospects and opportunities of Cancer Pain industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Pain market in Chapter 13.

    By Player:

    • ProStrakan Group

    • Sanofi

    • Eli-Lilly

    • BioDelivery Science

    • WEX Pharmaceuticals

    • Meda Pharmaceuticals

    • GW Pharmaceuticals

    • Teva pharmaceuticals

    • Orexo

    • Grunenthal Group

    • Johnson?Johnson

    By Type:

    • Opioids

    • Non-Steroidal Anti-Inflammatory Drugs

    • Others

    By End-User:

    • Paracetamol Treatment-Related Immunotherapy

    • Radiotherapy

    • Chemotherapy

    • Hormone

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer Pain Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer Pain Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer Pain Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer Pain Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer Pain Market Analysis and Outlook to 2022

    • 7.1 Global Cancer Pain Consumption (2017-2022)

    • 7.2 United States Cancer Pain Consumption (2017-2022)

    • 7.3 Europe Cancer Pain Consumption (2017-2022)

    • 7.4 China Cancer Pain Consumption (2017-2022)

    • 7.5 Japan Cancer Pain Consumption (2017-2022)

    • 7.6 India Cancer Pain Consumption (2017-2022)

    • 7.7 South Korea Cancer Pain Consumption (2017-2022)

    8 Region and Country-wise Cancer Pain Market Analysis and Outlook to 2028

    • 8.1 Global Cancer Pain Consumption Forecast (2022-2028)

    • 8.2 United States Cancer Pain Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer Pain Consumption Forecast (2022-2028)

    • 8.4 China Cancer Pain Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer Pain Consumption Forecast (2022-2028)

    • 8.6 India Cancer Pain Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer Pain Consumption Forecast (2022-2028)

    9 Global Cancer Pain Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer Pain Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Opioids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer Pain Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Paracetamol Treatment-Related Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Radiotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Hormone Consumption and Growth Rate (2017-2022)

    10 Global Cancer Pain Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer Pain Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Opioids Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer Pain Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Paracetamol Treatment-Related Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Hormone Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer Pain Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer Pain Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer Pain Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer Pain Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer Pain Market Competitive Analysis

    • 14.1 ProStrakan Group

      • 14.1.1 ProStrakan Group Company Details

      • 14.1.2 ProStrakan Group Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 ProStrakan Group Cancer Pain Product and Service

    • 14.2 Sanofi

      • 14.2.1 Sanofi Company Details

      • 14.2.2 Sanofi Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi Cancer Pain Product and Service

    • 14.3 Eli-Lilly

      • 14.3.1 Eli-Lilly Company Details

      • 14.3.2 Eli-Lilly Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eli-Lilly Cancer Pain Product and Service

    • 14.4 BioDelivery Science

      • 14.4.1 BioDelivery Science Company Details

      • 14.4.2 BioDelivery Science Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 BioDelivery Science Cancer Pain Product and Service

    • 14.5 WEX Pharmaceuticals

      • 14.5.1 WEX Pharmaceuticals Company Details

      • 14.5.2 WEX Pharmaceuticals Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 WEX Pharmaceuticals Cancer Pain Product and Service

    • 14.6 Meda Pharmaceuticals

      • 14.6.1 Meda Pharmaceuticals Company Details

      • 14.6.2 Meda Pharmaceuticals Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Meda Pharmaceuticals Cancer Pain Product and Service

    • 14.7 GW Pharmaceuticals

      • 14.7.1 GW Pharmaceuticals Company Details

      • 14.7.2 GW Pharmaceuticals Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GW Pharmaceuticals Cancer Pain Product and Service

    • 14.8 Teva pharmaceuticals

      • 14.8.1 Teva pharmaceuticals Company Details

      • 14.8.2 Teva pharmaceuticals Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Teva pharmaceuticals Cancer Pain Product and Service

    • 14.9 Orexo

      • 14.9.1 Orexo Company Details

      • 14.9.2 Orexo Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Orexo Cancer Pain Product and Service

    • 14.10 Grunenthal Group

      • 14.10.1 Grunenthal Group Company Details

      • 14.10.2 Grunenthal Group Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Grunenthal Group Cancer Pain Product and Service

    • 14.11 Johnson?Johnson

      • 14.11.1 Johnson?Johnson Company Details

      • 14.11.2 Johnson?Johnson Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Johnson?Johnson Cancer Pain Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer Pain

    • Figure Cancer Pain Picture

    • Table Global Cancer Pain Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Pain Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Pain Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer Pain Consumption by Country (2017-2022)

    • Figure United States Cancer Pain Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer Pain Consumption and Growth Rate (2017-2022)

    • Figure China Cancer Pain Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer Pain Consumption and Growth Rate (2017-2022)

    • Figure India Cancer Pain Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Pain Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer Pain Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Opioids Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Paracetamol Treatment-Related Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Radiotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hormone Consumption and Growth Rate (2017-2022)

    • Figure Global Opioids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Paracetamol Treatment-Related Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormone Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer Pain Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer Pain Export by Region (Top 5 Countries) (2017-2028)

    • Table ProStrakan Group (Foundation Year, Company Profile and etc.)

    • Table ProStrakan Group Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table ProStrakan Group Cancer Pain Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Cancer Pain Product and Service

    • Table Eli-Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli-Lilly Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli-Lilly Cancer Pain Product and Service

    • Table BioDelivery Science (Foundation Year, Company Profile and etc.)

    • Table BioDelivery Science Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioDelivery Science Cancer Pain Product and Service

    • Table WEX Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table WEX Pharmaceuticals Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table WEX Pharmaceuticals Cancer Pain Product and Service

    • Table Meda Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Meda Pharmaceuticals Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meda Pharmaceuticals Cancer Pain Product and Service

    • Table GW Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table GW Pharmaceuticals Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table GW Pharmaceuticals Cancer Pain Product and Service

    • Table Teva pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Teva pharmaceuticals Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva pharmaceuticals Cancer Pain Product and Service

    • Table Orexo (Foundation Year, Company Profile and etc.)

    • Table Orexo Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orexo Cancer Pain Product and Service

    • Table Grunenthal Group (Foundation Year, Company Profile and etc.)

    • Table Grunenthal Group Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grunenthal Group Cancer Pain Product and Service

    • Table Johnson?Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson?Johnson Cancer Pain Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson?Johnson Cancer Pain Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US